HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,544,988 | +13.3% | 720,529 | +7.7% | 0.54% | +15.8% |
| Q2 2023 | $56,946,740 | +6.1% | 668,860 | +3.1% | 0.47% | +0.9% |
| Q1 2023 | $53,697,054 | +9.2% | 648,907 | +3.8% | 0.46% | +7.2% |
| Q4 2022 | $49,176,384 | +5.6% | 625,256 | -0.6% | 0.43% | -6.3% |
| Q3 2022 | $46,552,000 | +17.5% | 628,825 | +3.4% | 0.46% | +23.3% |
| Q2 2022 | $39,628,000 | -24.6% | 607,976 | -26.8% | 0.37% | -13.8% |
| Q1 2022 | $52,529,000 | +54.4% | 830,890 | +29.5% | 0.43% | +59.0% |
| Q4 2021 | $34,021,000 | +4.8% | 641,433 | +39.5% | 0.27% | -4.9% |
| Q3 2021 | $32,463,000 | +122.0% | 459,873 | +109.6% | 0.29% | +120.8% |
| Q2 2021 | $14,624,000 | -42.5% | 219,454 | -4.2% | 0.13% | -47.2% |
| Q1 2021 | $25,428,000 | -16.1% | 229,055 | -10.2% | 0.25% | -23.8% |
| Q4 2020 | $30,301,000 | +36.3% | 255,172 | +0.2% | 0.32% | +16.6% |
| Q3 2020 | $22,228,000 | +24.1% | 254,764 | +27.4% | 0.28% | +14.5% |
| Q2 2020 | $17,914,000 | +2.7% | 200,016 | +14.3% | 0.24% | -12.9% |
| Q1 2020 | $17,440,000 | +24.9% | 175,002 | +44.1% | 0.28% | +71.6% |
| Q4 2019 | $13,958,000 | -7.0% | 121,485 | +2.1% | 0.16% | -14.3% |
| Q3 2019 | $15,003,000 | +5.6% | 118,939 | +0.8% | 0.19% | +2.2% |
| Q2 2019 | $14,202,000 | +35.7% | 118,019 | -1.3% | 0.18% | +30.3% |
| Q1 2019 | $10,462,000 | -31.4% | 119,592 | -21.5% | 0.14% | -41.6% |
| Q4 2018 | $15,249,000 | -39.6% | 152,406 | -30.8% | 0.24% | -30.2% |
| Q3 2018 | $25,249,000 | +21.0% | 220,361 | -5.3% | 0.35% | +13.7% |
| Q2 2018 | $20,873,000 | +7.1% | 232,744 | -12.6% | 0.31% | +3.4% |
| Q1 2018 | $19,492,000 | +16.9% | 266,424 | -7.2% | 0.30% | +21.3% |
| Q4 2017 | $16,671,000 | +26.0% | 287,036 | -2.6% | 0.24% | +18.4% |
| Q3 2017 | $13,227,000 | +11.8% | 294,791 | -1.6% | 0.21% | +8.4% |
| Q2 2017 | $11,831,000 | -25.0% | 299,597 | -22.9% | 0.19% | -22.8% |
| Q1 2017 | $15,766,000 | -55.1% | 388,618 | -55.5% | 0.25% | -11.5% |
| Q4 2016 | $35,120,000 | +85.7% | 873,642 | +67.2% | 0.28% | -10.9% |
| Q3 2016 | $18,916,000 | +24.3% | 522,419 | -0.5% | 0.31% | +20.0% |
| Q2 2016 | $15,220,000 | -18.0% | 524,997 | -1.1% | 0.26% | -19.5% |
| Q1 2016 | $18,560,000 | +8.8% | 530,588 | +0.3% | 0.32% | +2.2% |
| Q4 2015 | $17,051,000 | -26.8% | 528,869 | -26.6% | 0.32% | -18.8% |
| Q3 2015 | $23,302,000 | -25.0% | 720,956 | -4.0% | 0.39% | -17.9% |
| Q2 2015 | $31,073,000 | -13.5% | 751,266 | -6.1% | 0.47% | -11.1% |
| Q1 2015 | $35,930,000 | +13.5% | 799,883 | -5.4% | 0.53% | +13.2% |
| Q4 2014 | $31,654,000 | +2.7% | 845,905 | -4.1% | 0.47% | -1.1% |
| Q3 2014 | $30,810,000 | -3.4% | 882,311 | -2.4% | 0.48% | +2.8% |
| Q2 2014 | $31,888,000 | +11.2% | 903,866 | +2.7% | 0.46% | +8.7% |
| Q1 2014 | $28,669,000 | -23.2% | 879,696 | -0.7% | 0.43% | -21.8% |
| Q4 2013 | $37,334,000 | +22.9% | 886,153 | +16.3% | 0.54% | +17.2% |
| Q3 2013 | $30,380,000 | -5.1% | 761,786 | -1.6% | 0.46% | -10.1% |
| Q2 2013 | $32,005,000 | – | 774,013 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |